Illumina Body Map 2, young vs old
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFKB1 | hg19_v2_chr4_+_103422499_103422632 | 0.65 | 5.0e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_219745020 Show fit | 8.10 |
ENST00000258411.3
|
wingless-type MMTV integration site family, member 10A |
|
chr6_-_31550192 Show fit | 6.62 |
ENST00000429299.2
ENST00000446745.2 |
lymphotoxin beta (TNF superfamily, member 3) |
|
chr19_+_42381173 Show fit | 6.56 |
ENST00000221972.3
|
CD79a molecule, immunoglobulin-associated alpha |
|
chr6_+_31540056 Show fit | 6.10 |
ENST00000418386.2
|
lymphotoxin alpha |
|
chr19_+_17638059 Show fit | 5.82 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
family with sequence similarity 129, member C |
|
chr19_+_42381337 Show fit | 5.77 |
ENST00000597454.1
ENST00000444740.2 |
CD79a molecule, immunoglobulin-associated alpha |
|
chr22_-_37640277 Show fit | 5.66 |
ENST00000401529.3
ENST00000249071.6 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
chr1_-_202130702 Show fit | 5.47 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
protein tyrosine phosphatase, non-receptor type 7 |
|
chr22_-_37640456 Show fit | 5.40 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
chr16_+_50730910 Show fit | 5.30 |
ENST00000300589.2
|
nucleotide-binding oligomerization domain containing 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 16.8 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 14.1 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 13.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
1.0 | 11.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 8.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 8.9 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
2.9 | 8.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 8.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
2.7 | 8.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.5 | 8.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 25.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 18.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.0 | 14.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 13.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.8 | 12.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 12.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 11.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 10.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 9.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 8.7 | GO:0097542 | ciliary tip(GO:0097542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 24.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 22.2 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 18.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 15.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 11.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 11.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 10.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 10.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 8.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 7.7 | GO:0004568 | chitinase activity(GO:0004568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 23.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 18.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 17.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 17.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 12.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 11.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 11.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 7.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 7.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 7.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 28.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 21.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 15.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 12.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 12.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 11.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 8.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 8.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 7.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 6.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |